Brief: Revive Therapeutics enters into research collaboration with Sanyal Biotechnology for liver diseases
02/10/2017 12:00
Oct 2 (Reuters) - Revive Therapeutics Ltd RVV.V
* Revive Therapeutics enters into research collaboration
with Sanyal Biotechnology for liver diseases
Source text for Eikon: ID:nMKWFwKTYa
Further company coverage: RVV.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure